UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer

Molecular cancer, 2018-02, Vol.17 (1), p.38-38, Article 38

2018

Volltextzugriff (PDF)

Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI

Oncogene, 2019-01, Vol.38 (4), p.455-468

2019

Volltextzugriff (PDF)

Effectiveness of Tyrosine Kinase Inhibitors on Uncommon Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non―Small Cell Lung Cancer

Clinical cancer research, 2011-06, Vol.17 (11), p.3812-3821

2011

Volltextzugriff (PDF)

Ramucirumab or placebo plus erlotinib in EGFR‐mutated, metastatic non‐small‐cell lung cancer: East Asian subset of RELAY

Cancer science, 2020-12, Vol.111 (12), p.4510-4525

2020

Volltextzugriff (PDF)

Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first‐line gefitinib, erlotinib and afatinib‐treated non‐small cell lung cancer patients with activating EGFR mutations

International journal of cancer, 2019-06, Vol.144 (11), p.2887-2896

2019

Volltextzugriff (PDF)

Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer

International journal of cancer, 2019-09, Vol.145 (6), p.1609-1624

2019

Volltextzugriff (PDF)

Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2012-02, Vol.30 (4), p.433-440

2012

Volltextzugriff (PDF)

Different treatment efficacies and T790M acquisition of EGFR‐TKIs on NSCLC patients with variable Del‐19 subtypes of EGFR

International journal of cancer, 2023-07, Vol.153 (2), p.352-363

2023

Volltextzugriff (PDF)

Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C

Cancer letters, 2017-08, Vol.402, p.190-202

2017

Volltextzugriff (PDF)

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients

Oncotarget, 2016-03, Vol.7 (11), p.12404-12413

2016

Volltextzugriff (PDF)

MicroRNA in Lung Cancer Metastasis

Cancers, 2019-02, Vol.11 (2), p.265

2019

Volltextzugriff (PDF)

Stage Shift Improves Lung Cancer Survival: Real-World Evidence

Journal of thoracic oncology, 2023-01, Vol.18 (1), p.47-56

2023

Volltextzugriff (PDF)

Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer

PloS one, 2024-05, Vol.19 (5), p.e0303046

2024

Volltextzugriff (PDF)

Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial

The lancet oncology, 2012-05, Vol.13 (5), p.539-548

2012

Volltextzugriff (PDF)

Unique p53 and epidermal growth factor receptor gene mutation status in 46 pulmonary lymphoepithelioma‐like carcinomas

Cancer science, 2011-01, Vol.102 (1), p.282-287

2011

Volltextzugriff (PDF)

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

Proceedings of the National Academy of Sciences - PNAS, 2007-12, Vol.104 (52), p.20932-20937

2007

Volltextzugriff (PDF)

A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population

Lung cancer (Amsterdam, Netherlands), 2017-01, Vol.103, p.82-89

2017

Volltextzugriff (PDF)

LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis

Journal of biomedical science, 2023-09, Vol.30 (1), p.1-80, Article 80

2023

Volltextzugriff (PDF)

Association of pulmonary nontuberculous mycobacteria with the outcomes of patients with lung cancer: A retrospective matched cohort study with a special emphasis on the impact of chemotherapy

Journal of microbiology, immunology and infection, 2023-04, Vol.56 (2), p.392-399

2023

Volltextzugriff (PDF)

Identification of a Novel Biomarker, SEMA5A, for Non―Small Cell Lung Carcinoma in Nonsmoking Women

Cancer epidemiology, biomarkers & prevention, 2010-10, Vol.19 (10), p.2590-2597

2010

Volltextzugriff (PDF)

ERBB2 Amplification in NSCLC: How Many Faces?

Journal of thoracic oncology, 2024-05, Vol.19 (5), p.668-670

Shih, Jin-Yuan

2024

Volltextzugriff (PDF)

Multi‐kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin‐related protein 1

Molecular oncology, 2021-02, Vol.15 (2), p.560-578

2021

Volltextzugriff (PDF)

Assessing tumor angiogenesis using dynamic contrast-enhanced integrated magnetic resonance-positron emission tomography in patients with non-small-cell lung cancer

BMC cancer, 2021-04, Vol.21 (1), p.348-348, Article 348

2021

Volltextzugriff (PDF)

The association of EGFR amplification with aberrant exon 20 insertion report using the cobas EGFR Mutation Test v2

PloS one, 2024-04, Vol.19 (4), p.e0301120-e0301120

2024

Volltextzugriff (PDF)

Cell metabolomics analyses revealed a role of altered fatty acid oxidation in neurotoxicity pattern difference between nab-paclitaxel and solvent-based paclitaxel

PloS one, 2021-03, Vol.16 (3), p.e0248942

2021

Volltextzugriff (PDF)

1 – 25 von 360

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(324)
Mit Volltextzugriff
(334)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(269)
Life Sciences & Biomedicine
(242)
Humans
(183)
Oncology
(173)
Female
(122)
Male
(118)
Aged
(111)
Middle Aged
(109)
Lung Cancer
(99)
Lung Neoplasms - Genetics
(94)
Lung Neoplasms - Drug Therapy
(87)
Adult
(85)
Mutation
(85)
Lung Neoplasms - Pathology
(78)
Aged, 80 And Over
(70)
Respiratory System
(64)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(58)
Carcinoma, Non-Small-Cell Lung - Genetics
(52)
Biological And Medical Sciences
(49)
Medical Sciences
(49)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Thoracic Oncology
(31)
Lung Cancer
(23)
Journal Of Clinical Oncology
(21)
Cancer Research
(17)
Journal Of The Formosan Medical Association
(15)
Clinical Cancer Research
(10)
Clinical Lung Cancer
(7)
Plos One
(7)
Cancers
(6)
European Journal Of Cancer
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer

Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI

Effectiveness of Tyrosine Kinase Inhibitors on Uncommon Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non―Small Cell Lung Cancer

Ramucirumab or placebo plus erlotinib in EGFR‐mutated, metastatic non‐small‐cell lung cancer: East Asian subset of RELAY

Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first‐line gefitinib, erlotinib and afatinib‐treated non‐small cell lung cancer patients with activating EGFR mutations

Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer

Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer

Different treatment efficacies and T790M acquisition of EGFR‐TKIs on NSCLC patients with variable Del‐19 subtypes of EGFR

Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients

MicroRNA in Lung Cancer Metastasis

Stage Shift Improves Lung Cancer Survival: Real-World Evidence

Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer

Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial

Unique p53 and epidermal growth factor receptor gene mutation status in 46 pulmonary lymphoepithelioma‐like carcinomas

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population

LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis

Association of pulmonary nontuberculous mycobacteria with the outcomes of patients with lung cancer: A retrospective matched cohort study with a special emphasis on the impact of chemotherapy

Identification of a Novel Biomarker, SEMA5A, for Non―Small Cell Lung Carcinoma in Nonsmoking Women

ERBB2 Amplification in NSCLC: How Many Faces?

Multi‐kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin‐related protein 1

Assessing tumor angiogenesis using dynamic contrast-enhanced integrated magnetic resonance-positron emission tomography in patients with non-small-cell lung cancer

The association of EGFR amplification with aberrant exon 20 insertion report using the cobas EGFR Mutation Test v2

Cell metabolomics analyses revealed a role of altered fatty acid oxidation in neurotoxicity pattern difference between nab-paclitaxel and solvent-based paclitaxel

Suchergebnisse filtern